Diversified, LLC Bristol Myers Squibb CO Transaction History

Diversified, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$47.98 - $54.4 $201,372 - $228,316	4,197 New	4,197 $227,000
Q3 2023 Nov 02, 2023	BUY	$57.89 - $64.73 $23,040 - $25,762	398 Added 10.23%	4,287 $248,000
Q2 2023 Jul 26, 2023	SELL	$63.71 - $70.74 $9,301 - $10,328	-146 Reduced 3.62%	3,889 $248,000
Q1 2023 Apr 24, 2023	BUY	$65.71 - $74.53 $1,051 - $1,192	16 Added 0.4%	4,035 $279,000
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $25,269 - $29,922	369 Added 10.11%	4,019 $289,000
Q3 2022 Oct 25, 2022	BUY	$0.13 - $76.84 $474 - $280,466	3,650 New	3,650 $259,000
Q1 2021 May 05, 2021	SELL	$59.34 - $66.74 $144,255 - $162,244	-2,431 Closed	0 $0
Q4 2020 Jan 26, 2021	BUY	$57.74 - $65.43 $140,365 - $159,060	2,431 New	2,431 $147,000

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Diversified, LLC, based on Form 13F filings with the SEC.

Stay updated on Diversified, LLC with notifications on news.